Solid pancreatic lesions: Characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment - A preliminary study

Radiology

Volumn 266, Issue 1, 2013, Pages 185-196

  Kim, Jae Hyun ^a   Lee, Jeong Min ^b   Park, Ji Hoon ^b   Kim, Soo Chin ^b   Joo, Ijin ^b   Han, Joon Koo ^b   Choi, Byung Ihn ^b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DOSE RESPONSE; FEASIBILITY STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; LOW DRUG DOSE; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS BLOOD FLOW; PANCREAS CANCER; PANCREAS INJURY; PANCREAS RESECTION; PANCREATIC NEUROENDOCRINE TUMOR; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PANCREATIC DISEASES; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84871696420     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12120111     Document Type: Article

References (52)

1. Low G, Panu A, Millo N, Leen E. Multimodality imaging of neoplastic and nonneoplastic solid lesions of the pancreas. RadioGraphics 2011;31(4):993-1015.
2. Yu MH, Lee JY, Kim MA, et al. MR imaging features of small solid pseudopapillary tumors: retrospective differentiation from other small solid pancreatic tumors. AJR Am J Roentgenol 2010;195(6):1324-1332.
3. Baek JH, Lee JM, Kim SH, et al. Small (
4. Yoon SH, Lee JM, Cho JY, et al. Small (≤ 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology 2011;259(2):442-452.
5. Morgan KA, Adams DB. Solid tumors of the body and tail of the pancreas. Surg Clin North Am 2010;90(2):287-307.
6. Krzysztof K, Wiktor B, Tadeusz L, Waldemar B, Magdalena K, Janusz D. Neuroendocrine tumours: analysis of own material - a nine-year retrospective study. Hepatogastroenterology 2010;57(98):236-241.
7. Niedergethmann M, Grützmann R, Hildenbrand R, et al. Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience. World J Surg 2008;32(10):2253-2260.
8. Harinck F, Poley JW, Kluijt I, Fockens P, Bruno MJ; Dutch Research Group of Pancreatic Cancer Surveillance in High-Risk Individuals. Is early diagnosis of pancreatic cancer fiction? surveillance of individuals at high risk for pancreatic cancer. Dig Dis 2010;28(4-5):670-678.
9. Dietrich CF, Braden B, Hocke M, Ott M, Ignee A. Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound. J Cancer Res Clin Oncol 2008;134(6):635-643.
10. Casneuf VF, Delrue L, Van Damme N, et al. Noninvasive monitoring of therapy-induced microvascular changes in a pancreatic cancer model using dynamic contrast-enhanced magnetic resonance imaging with P846, a new low-diffusible gadolinium-based contrast agent. Radiat Res 2011;175(1):10-20.
11. Awasthi R, Rathore RK, Soni P, et al. Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers. Neuroradiology 2012;54(3):205-213.
12. Kul S, Cansu A, Alhan E, Dinc H, Gunes G, Reis A. Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. AJR Am J Roentgenol 2011;196(1):210-217.
13. Smith DS, Welch EB, Li X, et al. Quantitative effects of using compressed sensing in dynamic contrast enhanced MRI. Phys Med Biol 2011;56(15):4933-4946.
14. O'Connor JP, Rose CJ, Jackson A, et al. DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6. Br J Cancer 2011;105(1):139-145.
15. Hsu CY, Shen YC, Yu CW, et al. Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil. J Hepatol 2011;55(4):858-865.
16. Notohamiprodjo M, Sourbron S, Staehler M, et al. Measuring perfusion and permeability in renal cell carcinoma with dynamic contrast-enhanced MRI: a pilot study. J Magn Reson Imaging 2010;31(2):490-501.
17. Baxter S, Wang ZJ, Joe BN, Qayyum A, Taouli B, Yeh BM. Timing bolus dynamic contrast-enhanced (DCE) MRI assessment of hepatic perfusion: initial experience. J Magn Reson Imaging 2009;29(6):1317-1322.
18. Lin W, Guo J, Rosen MA, Song HK. Respiratory motion-compensated radial dynamic contrast-enhanced (DCE)-MRI of chest and abdominal lesions. Magn Reson Med 2008;60(5):1135-1146.
19. Song HK, Dougherty L. Dynamic MRI with projection reconstruction and KWIC processing for simultaneous high spatial and temporal resolution. Magn Reson Med 2004;52(4):815-824. (Pubitemid 39314984)
20. Dougherty L, Isaac G, Rosen MA, et al. High frame-rate simultaneous bilateral breast DCE-MRI. Magn Reson Med 2007;57(1):220-225. (Pubitemid 46067953)
21. Tamm EP, Balachandran A, Bhosale PR, et al. Imaging of pancreatic adenocarcinoma: update on staging/resectability. Radiol Clin North Am 2012;50(3):407-428.
22. Callery MP, Chang KJ, Fishman EK, Talamonti MS, William Traverso L, Linehan DC. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 2009;16(7):1727-1733.
23. Ehehalt F, Saeger HD, Schmidt CM, Grützmann R. Neuroendocrine tumors of the pancreas. Oncologist 2009;14(5):456-467.
24. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10(3):223-232. (Pubitemid 29463104)
25. Braren R, Curcic J, Remmele S, et al. Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping. Invest Radiol 2011;46(10):624-631.
26. Li KL, Zhu XP, Waterton J, Jackson A. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging 2000;12(2):347-357. (Pubitemid 30612881)
27. Song HK, Dougherty L, Schnall MD. Simultaneous acquisition of multiple resolution images for dynamic contrast enhanced imaging of the breast. Magn Reson Med 2001;46(3):503-509. (Pubitemid 32831325)
28. Song HK, Dougherty L. k-space weighted image contrast (KWIC) for contrast manipulation in projection reconstruction MRI. Magn Reson Med 2000;44(6):825-832.
29. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. I. Fundamental concepts. Magn Reson Med 1991;17(2):357-367.
30. Orton MR, d'Arcy JA, Walker-Samuel S, et al. Computationally efficient vascular input function models for quantitative kinetic modelling using DCE-MRI. Phys Med Biol 2008;53(5):1225-1239. (Pubitemid 351594423)
31. Tajima Y, Kuroki T, Tsutsumi R, Isomoto I, Uetani M, Kanematsu T. Pancreatic carcinoma coexisting with chronic pancreatitis versus tumor-forming pancreatitis: diagnostic utility of the time-signal intensity curve from dynamic contrast-enhanced MR imaging. World J Gastroenterol 2007;13(6):858-865. (Pubitemid 46470295)
32. Bali MA, Metens T, Denolin V, et al. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters. Radiology 2011;261(2):456-466.
33. Lee KH, Choi BI, Han JK, Jang HJ, Kim TK, Han MC. Nodular hepatocellular carcinoma: variation of tumor conspicuity on single-level dynamic scan and optimization of fixed delay times for two-phase helical CT. J Comput Assist Tomogr 2000;24(2):212-218. (Pubitemid 32206196)
34. Naish JH, Hutchinson CE, Caunce A, et al. Multiple-bolus dynamic contrast-enhanced MRI in the pancreas during a glucose challenge. J Magn Reson Imaging 2010;32(3):622-628.
35. Koh TS, Thng CH, Hartono S, et al. A comparative study of dynamic contrast-enhanced MRI parameters as biomarkers for anti-angiogenic drug therapy. NMR Biomed 2011;24(9):1169-1180.
36. Padhani AR, Khan AA. Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy. Target Oncol 2010;5(1):39-52.
37. Goh V, Padhani AR, Rasheed S. Functional imaging of colorectal cancer angiogenesis. Lancet Oncol 2007;8(3):245-255. (Pubitemid 46291714)
38. Hosoki T. Dynamic CT of pancreatic tumors. AJR Am J Roentgenol 1983;140(5):959-965. (Pubitemid 13134190)
39. Sofuni A, Iijima H, Moriyasu F, et al. Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroenterol 2005;40(5):518-525. (Pubitemid 40823288)
40. Delrue L, Blanckaert P, Mertens D, Van Meerbeeck S, Ceelen W, Duyck P. Tissue perfusion in pathologies of the pancreas: assessment using 128-slice computed tomography. Abdom Imaging 2012;37(4):595-601.
41. Lu N, Feng XY, Hao SJ, et al. 64-slice CT perfusion imaging of pancreatic adenocarcinoma and mass-forming chronic pancreatitis. Acad Radiol 2011;18(1):81-88.
42. d'Assignies G, Couvelard A, Bahrami S, et al. Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 2009;250(2):407-416.
43. Park MS, Klotz E, Kim MJ, et al. Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy. Radiology 2009;250(1):110-117.
44. Rodallec M, Vilgrain V, Couvelard A, et al. Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology 2006;6(1-2):77-85.
45. Fischer L, Kleeff J, Esposito I, et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg 2008;95(5):627-635.
46. Tan EH, Tan CH. Imaging of gastroenteropancreatic neuroendocrine tumors. World J Clin Oncol 2011;2(1):28-43.
47. Taylor B. Carcinoma of the head of the pancreas versus chronic pancreatitis: diagnostic dilemma with significant consequences. World J Surg 2003;27(11):1249-1257. (Pubitemid 37475718)
48. Sǎ;ftoiu A, Vilmann P, Gorunescu F, et al. Accuracy of endoscopic ultrasound elastography used for differential diagnosis of focal pancreatic masses: a multicenter study. Endoscopy 2011;43(7):596-603.
49. Yamada Y, Mori H, Matsumoto S, Kiyosue H, Hori Y, Hongo N. Pancreatic adenocarcinoma versus chronic pancreatitis: differentiation with triple-phase helical CT. Abdom Imaging 2010;35(2):163-171.
50. Spuentrup E, Katoh M, Buecker A, et al. Free-breathing 3D steady-state free precession coronary MR angiography with radial k-space sampling: comparison with cartesian k-space sampling and cartesian gradient-echo coronary MR angiography - pilot study. Radiology 2004;231(2):581-586. (Pubitemid 38552920)
51. Bokacheva L, Rusinek H, Chen Q, et al. Quantitative determination of Gd-DTPA concentration in T1-weighted MR renography studies. Magn Reson Med 2007;57(6):1012-1018. (Pubitemid 46915356)
52. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999;10(3):254-259. (Pubitemid 29463107)